These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9522537)

  • 1. [Cholestatic liver diseases--diagnosis and therapy. 3: Therapy of primary biliary cirrhosis].
    Leuschner U
    Fortschr Med; 1998 Jan; 116(1-2):37-9. PubMed ID: 9522537
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
    Levy C; Peter JA; Nelson DR; Keach J; Petz J; Cabrera R; Clark V; Firpi RJ; Morelli G; Soldevila-Pico C; Lindor K
    Aliment Pharmacol Ther; 2011 Jan; 33(2):235-42. PubMed ID: 21083674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestasis: drug therapy].
    Leuschner U
    Praxis (Bern 1994); 1998 Nov; 87(46):1532-6. PubMed ID: 9857764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of primary biliary cirrhosis. The effect of ursodeoxycholic acid is questioned now].
    Broomé U
    Lakartidningen; 2000 May; 97(21):2585-7. PubMed ID: 10881517
    [No Abstract]   [Full Text] [Related]  

  • 5. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations.
    Caponi A; Lisotti A; Grenci C; Roda E
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):331-4. PubMed ID: 19047973
    [No Abstract]   [Full Text] [Related]  

  • 6. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
    Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-].
    Rudi J; Schönig T; Stremmel W
    Z Gastroenterol; 1996 Mar; 34(3):188-91. PubMed ID: 8650973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study.
    Nakai S; Masaki T; Kurokohchi K; Deguchi A; Nishioka M
    Am J Gastroenterol; 2000 Jan; 95(1):326-7. PubMed ID: 10638623
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
    Treiber G; Malfertheiner P
    J Clin Gastroenterol; 2005 Oct; 39(9):837-8; author reply 838. PubMed ID: 16145353
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Kurihara T; Niimi A; Maeda A; Shigemoto M; Yamashita K
    Am J Gastroenterol; 2000 Oct; 95(10):2990-2. PubMed ID: 11051391
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia.
    Willot S; Uhlen S; Michaud L; Briand G; Bonnevalle M; Sfeir R; Gottrand F
    Pediatrics; 2008 Dec; 122(6):e1236-41. PubMed ID: 19029197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
    Kaplan MM; Cheng S; Price LL; Bonis PA
    Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].
    Thimme R; Opitz OG; Kreisel W
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1823-6. PubMed ID: 12215926
    [No Abstract]   [Full Text] [Related]  

  • 19. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.